Homepage English
Homepage Nederlands
Contact
Organisation
Research
Events
Clinical Research Bureau
Links
Funding
Portfolio
PEG-IFN HBV Treatment Index

PEG-IFN HBV Treatment Index

Factors that Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa
Erik. H.C.J. Buster, Bettina E. Hansen, George K.K. Lau , Teerha Piratvisuth, Stefan Zeuzem, Ewout W. Steyerberg and Harry L.A. Janssen
Gastroenterology 2009; 137(6): 2002-2009

PEG-IFN HBV Treatment Index

HBV genotype:  
Sex:
Age:
 18-80
Serum ALT (x ULN):
 0-20
Serum HBV DNA (log10 copies/ml)*: 
 1-15
Previous interferon therapy:
 
 
 

 

 

 

* for HBV DNA expressed in IU/ml please multiply the test result by 5
** HBeAg loss and HBV-DNA level less than 1.0x104 copies/ml 6 months after treatment
  
Contact information
Foundation for Liver and Gastrointestinal Research
P/A Erasmus MC, Room Ha 204
Address
's Gravendijkwal 230
3015 CE Rotterdam
colofon - disclaimer